Immunoglobulin A with protease activity secreted in human milk activates PAR-2 receptors, of intestinal epithelial cells HT-29, and promotes beta-defensin-2 expression

被引:20
作者
Barrera, G. J.
Portillo, R. [2 ]
Mijares, A. [2 ]
Rocafull, M. A.
del Castillo, J. R.
Thomas, L. E. [1 ]
机构
[1] IVIC, Ctr Biofis & Bioquim, Lab Fisiol Mol, Caracas 1020A, Venezuela
[2] IVIC, Lab Fisiol Parasitos, Caracas 1020A, Venezuela
关键词
Human milk; Breastfeeding; sIgA; Defensin; Natural catalytic antibodies; PAR-2; CATALYTIC ANTIBODIES; PATHOPHYSIOLOGY; IGG;
D O I
10.1016/j.imlet.2009.02.001
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
071005 [微生物学]; 100108 [医学免疫学];
摘要
Secretory antibodies of the immunoglobulin A (sIgA) class constitute the first line of antigen-specific immune protection against pathogens and other antigens at mucosal surfaces. Although initially perceived as potentially deleterious, catalytic antibodies have been proposed to participate in the removal of metabolic wastes and in protection against infection. Here we show that the presence of slgA endowed with serine protease-like hydrolytic activity in milk strongly correlates with PAR-2 activation in human intestinal epithelial cells. F(ab')(2) fragments of sIgA activated the epithelial cells in culture to produce beta-defensin-2 (hBD2). Intracellular Ca2+ Mobilization was induced by treatment with (1) sIgA-F(ab')(2) fragments; (2) trypsin, a recognized PAR-2 agonist; or (3) a synthetic PAR-2 agonist peptide (SLIGKV). The co-treatment with a synthetic PAR-2 antagonist peptide (FSLLRY) and sIgA-F(ab')(2) fragments eliminates the latter's effect; nevertheless, cells were not refractory to subsequent stimulation with sIgA-F(ab')(2) fragments. Both the induction of hBD-2 expression in epithelial cells and the increase in intracellular [Ca2+] stimulated by sIgA-F(ab')(2) fragments were inhibited by treatment with serine protease inhibitors or pertussis toxin (PTX). These findings suggest that catalytic antibodies can activate intestinal epithelial cells through G-protein-coupled PAR-2, and could actively participate in the immune system of breastfed babies inducing the production of peptides related to innate defense, such as defensins. (C) 2009 Elsevier B.V. All rights reserved.
引用
收藏
页码:52 / 59
页数:8
相关论文
共 27 条
[1]
Modified proteinase-activated receptor-1 and-2 derived peptides inhibit proteinase-activated receptor-2 activation by trypsin [J].
Al-Ani, B ;
Saifeddine, M ;
Wijesuriya, SJ ;
Hollenberg, MD .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2002, 300 (02) :702-708
[2]
Modulation of membrane type I matrix metalloproteinase by LPS and gamma interferon bound to extracellular matrix in intestinal crypt cells [J].
Alvarado, Jansi ;
del Castillo, Jesus R. ;
Thomas, Luz. E. .
CYTOKINE, 2008, 41 (02) :155-161
[3]
Protease-activated receptor signaling increases epithelial antimicrobial peptide expression [J].
Chung, WO ;
Hansen, SR ;
Rao, D ;
Dale, BA .
JOURNAL OF IMMUNOLOGY, 2004, 173 (08) :5165-5170
[4]
Protease-activated receptor 2 mediates human beta-defensin 2 and CC chemokine ligand 20 mRNA expression in response to proteases secreted by Porphyromonas gingivalis [J].
Dommisch, Henrik ;
Chung, Whasun O. ;
Rohani, Maryam G. ;
Williams, David ;
Rangarajan, Minnie ;
Curtis, Mike A. ;
Dale, Beverly A. .
INFECTION AND IMMUNITY, 2007, 75 (09) :4326-4333
[5]
Breastfeeding provides passive and likely longlasting active immunity [J].
Hanson, LÅ .
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 1998, 81 (06) :523-537
[6]
HE SH, 2008, ACTA PHARM SIN, V26, P568
[7]
Activation of protease-activated receptor 2 stimulates proliferation and interleukin (IL)-6 and IL-8 secretion of endometriotic stromal cells [J].
Hirota, Y ;
Osuga, Y ;
Hirata, T ;
Harada, M ;
Morimoto, C ;
Yoshino, O ;
Koga, K ;
Yano, T ;
Tsutsumi, O ;
Taketani, Y .
HUMAN REPRODUCTION, 2005, 20 (12) :3547-3553
[8]
Kallikreins and proteinase-mediated signalling: proteinase-activated receptors (PARs) and the pathophysiology of inflammatory disease and cancer [J].
Hollenberg, Morley D. ;
Oikonomopoulou, Katerina ;
Hansen, Kristina K. ;
Saifeddine, Mahmoud ;
Ramachandran, Rithwik ;
Diamandis, Eleftherios P. .
BIOLOGICAL CHEMISTRY, 2008, 389 (06) :643-651
[9]
KAWABATA A, 2007, BRIT J PHARMACOL, V153, pS230
[10]
Pathophysiology of catalytic antibodies [J].
Lacroix-Desmazes, S ;
Wootla, B ;
Delignat, S ;
Dasgupta, S ;
Nagaraja, V ;
Kazatchkine, MD ;
Kaveri, SV .
IMMUNOLOGY LETTERS, 2006, 103 (01) :3-7